Tender

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study

  • University of Leicester

F02: Contract notice

Notice identifier: 2021/S 000-006678

Procurement identifier (OCID): ocds-h6vhtk-02a187

Published 31 March 2021, 2:32pm



Section one: Contracting authority

one.1) Name and addresses

University of Leicester

University Road

Leicester

LE1 7RH

Contact

Anthony Midgley

Email

acm26@le.ac.uk

Telephone

+44 1162522058

Country

United Kingdom

NUTS code

UK - UNITED KINGDOM

Internet address(es)

Main address

http://le.ac.uk

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://www.delta-esourcing.com/tenders/UK-UK-Leicester:-Research-and-development-services-and-related-consultancy-services./N469R94W9G

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Education


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study

Reference number

LUV00996

two.1.2) Main CPV code

  • 73000000 - Research and development services and related consultancy services

two.1.3) Type of contract

Services

two.1.4) Short description

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study

two.1.5) Estimated total value

Value excluding VAT: £1,057,433

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM
Main site or place of performance

UNITED KINGDOM

two.2.4) Description of the procurement

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study. COLO-PREVENT will assess whether intervention with the API resveratrol is able to affect recurrence of colorectal adenomas within the NHS Bowel Cancer Screening Programme.

Award of contract is dependent on: a)prior receipt by the University of an award letter from the funder (CRUK) and b) a cap on the overall budget of £1,268,920 including VAT at 20%.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £1,057,433

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Start date

1 June 2021

End date

31 May 2031

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: Yes

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

To respond to this opportunity please click here: https://www.delta-esourcing.com/respond/N469R94W9G


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions

See procurement documents

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

6 May 2021

Local time

12:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 3 (from the date stated for receipt of tender)

four.2.7) Conditions for opening of tenders

Date

6 May 2021

Local time

1:00pm

Place

Leicester

Information about authorised persons and opening procedure

Electronically via the Delta eTendering portal.


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.3) Additional information

The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.

For more information about this opportunity, please visit the Delta eSourcing portal at:

https://www.delta-esourcing.com/tenders/UK-UK-Leicester:-Research-and-development-services-and-related-consultancy-services./N469R94W9G

To respond to this opportunity, please click here:

https://www.delta-esourcing.com/respond/N469R94W9G

GO Reference: GO-2021331-PRO-18014509

six.4) Procedures for review

six.4.1) Review body

Royal Courts of Justice

Strand

London

WC2A 2LL

Country

United Kingdom

six.4.2) Body responsible for mediation procedures

See VI.4.1 above

See VI.4.1 above

Country

United Kingdom

six.4.4) Service from which information about the review procedure may be obtained

See VI.4.1 above

See above

Country

United Kingdom